Intraosseous Infusion Devices Market is estimated to be valued at USD 1,112.1 Mn in 2025 and is expected to reach USD 1,607. Mn in 2032, exhibiting a compound annual growth rate (CAGR) of 5.4% from ...

report provides actionable intelligence on factors that have been driving demand; key trends that are impacting the market; challenges that affect the market dynamics along with the market size, a ...

The global intraosseous infusion devices market is on a strong growth trajectory, with projections indicating a significant rise from USD 5,065.8 million in 2025 to USD 10,463.8 million by 2035. This ...

The global industry for intraosseous infusion devices is poised for substantial growth, with an estimated value of USD 5,065.8 million in 2025. The market is expected to reach USD 10,463.8 million by ...

Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Type (Manual IO Needles, Battery Powered Driver), By End-use (Hospitals and ...

PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a diversified commercial-stage medical technology company, today announced that physicians at the Clinica Porto Azul in Barranquilla, ...

First three patients underwent successful implantation and clinical utilization of PortIO as part of a first-in-human study in Colombia, South America NEW YORK--(BUSINESS WIRE)--PAVmed Inc. (Nasdaq: ...

Teleflex TFX recently launched the Arrow EZ-IO Intraosseous Access Procedure Tray, which contains all the components required for the IO access procedure. The tray includes the first FDA-cleared ...